Price-action and technical news — breakouts, momentum, and chart moves — across stocks and assets.
LatestPrice Action
Price Action▲
Dell Falls 2.5% as $1,199 Googlebook Tests PC Margin
Dell Technologies entered Google's push into premium AI laptops with the new XPS Googlebook, a $1,199 machine pairing a 13-inch design with Qualcomm's Snapdragon X Elite and software built around Google's Gemini AI, and shares fell approximately 2.5% to $561.01. The laptop is only one piece of Dell's AI story: the company's latest quarter generated a record $60.9 billion of AI-server orders and $16.4 billion of AI-server revenue, giving Dell a much bigger growth engine behind the new consumer device. The valuation picture is harder to ignore, with Dell's $561.01 share price sitting 143.19% above the $230.69 GF Value estimate. The Googlebook adds another premium product and could deepen Dell's position across AI devices, but there is no disclosed sales target, margin outlook or unit commitment yet. For investors, the bigger question is whether Dell can turn this new AI-PC exposure into meaningful earnings growth while its valuation already leaves little room for disappointment.
Rosenblatt Initiates Sandisk at Buy With $2,400 Target, Shares Jump 6.6%
Rosenblatt initiated coverage of Sandisk with a Buy rating and a $2,400 price target, sending the NAND-flash and data-storage producer's shares up approximately 6.6% to $1,884.05. Rosenblatt analyst Kevin Cassidy sees NAND becoming a more important piece of the computing stack as AI workloads expand beyond processors into massive pools of high-speed storage. Sandisk's fiscal fourth-quarter revenue reached $8.97 billion, up 51% sequentially, as management leans into enterprise solid-state drives and its manufacturing partnership with Kioxia. At $1,884.05, the $2,400 target implies roughly 27.4% additional upside. Sandisk's GF Score sits at just 51 out of 100, with standout growth and financial strength offset by much weaker GF Value and momentum readings.
Nektar Therapeutics Falls 11% as Jury Deliberates in Eli Lilly Rezpeg Patent Dispute
Nektar Therapeutics shares sank 11% as a jury deliberated in its patent dispute with Eli Lilly over its Rezpeg drug. The jury in San Francisco federal court has been deliberating since Friday, and the trial started earlier this month. Court observers told Seeking Alpha on Tuesday that the stock may have dropped after the jury asked about low and no damage results in the dispute.
AMD Briefly Tops $1 Trillion Market Cap as AI Agent Demand Lifts CPU Makers
Advanced Micro Devices briefly crossed a $1 trillion market capitalization for the first time Monday, as surging demand tied to AI agents pushed investors toward central processing unit makers. AMD shares jumped more than 8% to a record $615.99 before closing near $609.65, leaving the chipmaker valued at roughly $995 billion. AMD became the fourth U.S. chipmaker to cross the $1 trillion threshold, joining Nvidia, Broadcom and Micron, while Intel jumped 12.03% to $121.67 and Arm Holdings surged 15.47% in the same session. The catalyst is the rapid adoption of Meta Platforms' Muse consumer AI app, which recently climbed to the top of the U.S. iPhone App Store, since running live software agents requires substantial CPU capacity alongside graphics processors. Intel CEO Lip-Bu Tan said CPU demand has become so strong that the company can currently fulfill only about half of customer orders, and AMD CEO Lisa Su said the company has raised its server CPU total addressable market outlook to grow more than 35% annually and exceed $120 billion by 2030, with the broader data-center CPU opportunity potentially reaching as much as $220 billion.
Intel Rises 0.5% as Meta's Muse Agent Revives Server CPU Thesis
Intel shares gained approximately 0.5% to $122.46 as Meta's Muse agent revived the case for server CPUs in an AI market dominated by accelerators. The Muse agent runs through its own virtual computer and can keep working on longer tasks even after a user exits the application, creating demand for general-purpose compute around the model itself. Intel is trying to capture that layer as its business rebounds, with second-quarter revenue rising 25% to $16.1 billion and the company rolling out its Xeon 6+ server processor built on Intel 18A. Still, Muse is evidence of a potentially expanding workload, not evidence of an Intel design win, and Intel now trades 281.26% above its $32.12 GF Value estimate. The real payoff comes only if autonomous agents drive incremental server deployments and Intel wins enough of that spending at attractive margins, making Xeon availability, power efficiency, hyperscaler adoption and Intel 18A execution the numbers investors should watch.
Wells Fargo Downgrades Netflix on Engagement Risks From YouTube
Wells Fargo downgraded Netflix after flagging weaker viewer engagement and rising pressure from rivals such as YouTube, intensifying concerns about how much time subscribers spend on the platform. The downgrade has thrown a spotlight on whether Netflix's push into formats like live sports, video podcasts, and short-form "Verts" can meaningfully revive engagement. Netflix's narrative projects $65.5 billion revenue and $19.8 billion earnings by 2029, requiring 10.6% yearly revenue growth and a $6.2 billion earnings increase from $13.6 billion today. Before this downgrade, the most optimistic analysts were banking on Netflix lifting earnings to about US$21.8 billion by 2029, with richer margins, while also warning that heavier content spending could bite into profits if engagement slows. Netflix's forecasts yield a $94.04 fair value, a 28% upside to its current price.
Meta's Muse AI Agent Sparks Selloff in Banks, Insurers and Travel Stocks
Shares of major banks, insurers and online travel agencies slid on Tuesday as investors feared that tools like Meta Platforms Inc.'s personal AI agent could disrupt businesses that benefit from so-called consumer inertia. The S&P 500 Financials Index dropped as much as 2.4% to its lowest levels since July, with JPMorgan Chase & Co., Morgan Stanley and Wells Fargo & Co. all declining more than 2.5%, while insurer Allstate Corp. and brokerage Charles Schwab Corp. fell more than 5%. Travel booking companies were also hit, with Expedia Group Inc. down 3.7% and Booking Holdings Inc. falling 3.9%, and in Europe telecommunications was the worst performing sector in the benchmark Stoxx 600 as France's Orange SA and British carrier BT Group Plc each dropped about 4%. The downturn came as Muse, Meta's new AI agent, rose to the top of Apple Inc.'s US app store, sending Meta shares up 11% on Monday. Goldman Sachs Group Inc.'s trading desk said telecoms, insurance and utilities are the industries to watch if AI agents make it easier and cheaper to switch service providers, naming AT&T Inc., T-Mobile US Inc., Allstate, Progressive Corp., Netflix Inc., Paramount Skydance Corp., Expedia and Booking among its basket of consumer inertia stocks at risk.
AMD Tops $1 Trillion Market Cap as Shares Surge 9% to Record
Advanced Micro Devices crossed the $1 trillion market-cap threshold for the first time Monday, becoming the fourth U.S. chipmaker to reach that level. AMD shares surged more than 9% to a record $611.57, extending their 2026 gain to roughly 173%. The rally was not limited to AMD: Intel climbed about 12%, Micron gained roughly 3%, and Nvidia advanced around 1.4%, helping push the Philadelphia Semiconductor Index up more than 3%, while the Nasdaq Composite gained about 1.6%. AMD now joins Nvidia, Broadcom and Micron in the trillion-dollar semiconductor club. Macro conditions also helped, with Brent crude falling more than 3% to roughly $100.62 a barrel and the 10-year Treasury yield slipping to 4.96% from 5.01% on Friday. Investors are also looking toward President Donald Trump's September 24 meeting with Chinese President Xi Jinping, and Treasury Secretary Scott Bessent said the U.S. and China had formalized a dialogue around AI and plan to meet again in Shenzhen in two months.
FDA Tells Compass Therapeutics to Run Survival Trial Before Tovecimig BLA
Compass Therapeutics said the FDA recommended it run a trial demonstrating a survival benefit before submitting a BLA for tovecimig in biliary tract cancer, while the company stated it does not believe a new trial is warranted prior to submitting a BLA. In the Phase 2/3 COMPANION-002 study, tovecimig plus paclitaxel showed a statistically significant improvement in objective response rate of 18.0% versus 5.3% with paclitaxel alone, and median progression-free survival of 4.7 versus 2.6 months with a hazard ratio of 0.44, a 56% reduction in the risk of disease progression. Overall survival analyses were confounded by high crossover and prolonged survival in crossover patients randomized to the control arm and then treated with tovecimig, and therefore did not meet statistical significance. Compass Therapeutics shares were down 29.40% at $1.28 at the time of publication, trading at a new 52-week low.
OpenAI, Anthropic and SpaceX Combined Valuation Tops $5.2 Trillion, Eclipsing Decades of Tech IPOs
OpenAI, Anthropic and SpaceX have reached a combined valuation of roughly $5.2 trillion, eclipsing the $4.1 trillion first-day value generated by 3,365 U.S. technology IPOs between 1980 and 2025. That $5.2 trillion total includes approximately $2 trillion for SpaceX, $2 trillion for Anthropic and $1.2 trillion for OpenAI, with OpenAI and Anthropic alone accounting for about $3.2 trillion, or roughly 62% of the three-company total, despite neither having reached public markets. SpaceX priced its June IPO at $135 per share, initially valuing it around $1.75 trillion, then opened at $150 and finished its first session at $160.95, pushing its market capitalization to roughly $2.1 trillion after raising about $75 billion. The stock later reached an intraday record of $225.64 before retreating sharply, closing Monday at $151.85, about 5.7% below its first-day close and nearly 33% below its record high. OpenAI has pushed back its IPO timetable and is not expected to list in 2026, while Anthropic has reportedly been considering a November offering at a valuation as high as $2 trillion, although timing and terms could still change.
Gabelli Fund Cites Herc Holdings as Top Q2 Contributor on 45% Surge
Herc Holdings Inc. was the largest contributor to the Gabelli Focused Growth and Income Fund in the second quarter of 2026, surging approximately 45% as the market re-rated the shares following first quarter results that far exceeded expectations. The Fund, which declined 1.61% in the quarter, held Herc Holdings at 2.5% of net assets as of June 30, 2026. Equipment rental revenue rose 33% to $981 million, adjusted EBITDA increased 33% to $448 million, and adjusted earnings of $0.21 per diluted share came in well ahead of consensus estimates. Management affirmed full year 2026 guidance of $4.275–$4.4 billion in equipment rental revenue and $2.0–$2.1 billion in adjusted EBITDA, supported by strong national account activity and a growing mega-project pipeline. Herc pays a quarterly dividend of $0.70 per share, or $2.80 annualized.
Shopify Shares Jump 8.9% on Meta Muse Agentic Checkout Partnership
Shopify shares surged as much as 8.9% on Wednesday after the e-commerce platform announced a partnership with Meta Platforms to let Meta's Muse AI agent complete purchases on Shopify stores. As of 11:59 a.m. ET, the stock was still up 7.3%. Under the deal, Muse will be able to complete transactions on behalf of its users through Shop Pay across all Shopify stores, a move CEO Tobi Lütke announced in a post on X. The partnership contrasts with Amazon's decision to block Muse from accessing its platform, saying continued access by an unauthorized AI agent violates Amazon's Conditions of Use. Meta's Muse personal AI agent, released earlier this month, drew 730,000 downloads in its first five days after debuting on Sept. 8, according to Sensor Tower data cited by CNBC, and has climbed to the top of Apple's App Store free app charts.
Root Shares Fall 12% as Premium Growth Slows and Claims Costs Rise
Root, Inc. shares have fallen 12% over the past month as slower premium growth and higher loss costs weighed on an otherwise profitable quarter. Gross written premium declined 1.9% year over year to $339.7 million in the second quarter of 2026, and management expects year-end 2026 policies in force to be relatively flat if current direct auto competition persists. Profitability held up, with second-quarter net income up 15.5% to $25.4 million, adjusted EBITDA up 16.5% to $43.8 million, and the net combined ratio improving 310 basis points to 92.1%; for the first half of 2026, adjusted EBITDA reached $100.6 million versus $69.5 million a year earlier. The gross accident-period loss ratio rose to 61.6% from 57.4% a year earlier on vehicle repair costs, medical inflation and channel mix, and management expects the usual seasonal rise in loss ratios in the second half of 2026. Root plans to launch its next predictive pricing model in the fourth quarter of 2026, with a more material impact expected in 2027, while its exclusive embedded insurance partnership with Carvana, which surpassed 200,000 policies sold, now runs through at least August 2028.
Fastenal Earns Zacks Rank #2 Upgrade on Stronger Earnings Outlook
Fastenal received a Zacks Rank #2 rating, reflecting a stronger full year earnings outlook for the industrial distributor. The upgrade arrives after a 22.8% year-to-date share price gain, a 90 day return of 8.9%, and a 3 year total shareholder return of 94.8%, though the 30 day return has slipped 3.1% to around US$49.65. The most followed valuation narrative pegs fair value at about $48.84, slightly below the recent close, implying the stock is 2% overvalued. Fastenal is expanding its Fastenal Managed Inventory technology, which currently represents over 43% of revenue, and aims to lift its digital footprint to 66-68% of sales from 61%. Key risks to that fair value story include higher tariff related costs hitting margins and weaker pricing power than analysts have assumed.
Meta Rallies as Muse AI Chatbot Tops App Store Downloads
Meta Platforms stock is trying to hold onto gains from a rally sparked by the release of its new Muse AI chatbot, which yesterday sent the market buzzing up like 11% and became the number one downloaded app in the App Store. On the Today's Market Hang panel, Interactive Brokers chief strategist Steve Sosnick said the stock was actually the most sold on the Interactive Brokers platform as customers took profits and sold into the rally. Gerber Kawasaki Wealth & Investment Management CEO Ross Gerber said he does not use Instagram or any Meta product, citing trust concerns and asking why anyone would give Muse access to their phone and personal information when Facebook cannot be trusted. Sosnick echoed that concern, saying he does not need more Facebook, more Meta, or more Zuckerberg in his life. Gerber argued trust is a main factor people are discounting for AI agents, and that Apple holds the pole position if it can build something better than Apple Intelligence. Defiance ETFs CIO Sylvia Jablonski said Meta has an enormous structural advantage given its existing user base and digital footprint, making Muse a service within behavior users already have, though she agreed trust remains the issue.
AutoZone reported fourth-quarter earnings per share of $56.05, beating the $54.30 analyst consensus, while net sales of $6.6 billion fell short of the $6.71 billion expected, sending its shares up 6% to $2,977.26 in Tuesday trading. The profit beat and revenue miss split the market's read, with margin and execution holding up even as the top line failed to clear the bar. Chief Executive Phil Daniele said that despite a difficult selling environment in the first eight weeks of the quarter, sales strengthened over the final eight weeks and the company is well positioned for sales growth in fiscal 2027. The read-across lifted peers that reported nothing of their own: Advance Auto Parts rose 6% to $43.29 and O'Reilly Automotive gained 4% to $86.24, as traders extrapolated AutoZone's results to demand across the aftermarket group. AutoZone shares entered the session down 13% year to date, so the move reads as a recovery off a weak base rather than a fresh breakout, and the sympathy bids in Advance Auto Parts and O'Reilly Automotive will need confirmation from each company's own quarter before the read becomes a confirmed trend.
McDonald's Faces Pivotal Investor Day After 18% Stock Drop
McDonald's will hold a closely watched investor day in Chicago on Wednesday, its final chance this year to reverse an 18% decline in its stock price. Jefferies analyst Andy Barish wrote that the September 23 event could prove a crucial clearing event if management articulates a credible path to reaccelerating same-store sales in the fourth quarter and 2027, protecting and growing operating margins, and still accelerating unit growth despite the tough macro. The company's recent initiatives, including a McValue menu with 10 items under $3, six new caffeinated drinks launched May 6, and a nationwide August 17 rollout of its Red Bull Dragonberry Energizer, failed to generate the incremental traffic McDonald's was banking on in the second quarter. McDonald's US comparable sales rose just 0.8%, far behind the 8.5% year-over-year gain at Restaurant Brands International-owned Burger King US, which beat analyst expectations. Barish said he expects a relatively quick adjustment to the marketing and menu innovation calendars that drove summer execution issues, noting that some digital promos returned August 10, Spicy Chicken McNuggets came back September 1, and a Spongebob x One Piece promo starts September 15.
McDonald's Revives Monopoly With $1 Million Prize as Stock Hits Two-Year Low
McDonald's is bringing back its Monopoly promotion on October 6, 2026, with a $1 million grand prize, as the fast-food chain's stock trades near a two-year low. The grand prize is paid as a $50,000-per-year annuity over 20 years with no interest, not a lump sum, according to the official rules. The prize pool also includes a 2027 Jeep Cherokee, a Carnival Cruise vacation, a trip to the Kennedy Space Center Visitor Complex, five 2026 Jeep Grand Cherokee Limited prizes via Bonus Play running through November 2, Coca-Cola experience packages, $50,000 toward a home down payment or college debt via Chance Cards, and a Free for a Year McDonald's gift card worth roughly $1,040. Gameplay now runs entirely through the McDonald's app, with customers peeling physical game piece codes off eligible food and drink purchases and scanning them in the app, and customers can pre-register between September 29 and October 5 for 500 bonus MyMcDonald's Rewards points. The promotion will not return to the UK or Australia in 2026. McDonald's traded at $250.32 as of 11:35 AM Eastern on September 22, 2026, up 0.98% in the session, but down 16.49% year to date from $299.76 at the end of last year, down 15.08% over one year, and down 6.96% over the past month, while up 15.69% over five years. The stock hit a new 52-week low on the same day it reached Dividend King status with 50 consecutive years of dividend increases, and US comparable sales softened to 0.8% in the second quarter of 2026, with global comparable sales decelerating to 1.3%. Analysts have cut their price targets broadly, with TD Cowen going to $282 from $300 with a Hold, Deutsche Bank to $300 from $325 while keeping a Buy, Morgan Stanley to $308 from $319 at Equalweight, Citi to $310 from $345, RBC to $290 from $295, and UBS to $320 from $340.
Defense stocks slide as Trump floats Iran peace deal at UN
Aerospace and defense stocks fell broadly Tuesday after President Donald Trump raised the prospect of a negotiated end to the U.S. conflict with Iran during an address to the United Nations, while warning that military action could intensify if Tehran refuses to reach an agreement. V2X fell about 3.8%, Kratos Defense & Security Solutions dropped 3.7% and Karman Holdings declined 3.5%, while BAE Systems was down 2.9%, Northrop Grumman fell 2.8% and Lockheed Martin lost 2.7%; General Dynamics, Huntington Ingalls, L3Harris Technologies and RTX also traded lower. Trump told the UN General Assembly he expects the United States eventually to reach an agreement with Iran and believes Tehran will make a deal after the U.S. midterm elections on Nov. 3, and Reuters reported, citing a senior Iranian official, that Iran offered to reopen the Strait of Hormuz within seven days if Washington reduces military pressure and ends its blockade of Iranian ports, with Iran's UN delegation authorized to restart diplomatic negotiations. Trump also said the United States has ample munitions and is producing them at unprecedented levels, addressing concerns that months of fighting have depleted U.S. weapons inventories, including Tomahawk cruise missiles, Patriot interceptors and THAAD interceptors. He separately predicted progress toward ending Russia's war in Ukraine, saying the United States was working with Russian and Ukrainian leaders and suggesting an agreement could come sooner than expected, leaving defense investors weighing possible negotiated settlements against the longer-term need to replenish weapons stockpiles.
Quest Diagnostics Falls 5.1% After CMS Cuts Lab Reimbursement Rates
Quest Diagnostics stock dropped 5.1% through 11:30 a.m. Tuesday after the Centers for Medicare & Medicaid Services disclosed Monday that it has been paying about 16% more for lab work than private insurers pay. Effective Jan. 1, 2027, CMS says it will cut reimbursement rates for lab costs by up to 15%, a move the agency estimates will save taxpayers $1 billion per year. Quest Diagnostics disclosed in its 10-K filing with the SEC that it received approximately 11% of its revenue from CMS reimbursement in 2025, and the company flagged reductions in Medicare and Medicaid rates as a key risk to its testing volume and collected revenue. If CMS cuts rates by the full 15%, Quest Diagnostics' annual revenue would decrease by 1.65%, and with successive 15% per year reductions possible from 2027 through 2029, the worst-case scenario implies a reduction of slightly less than 5% in its business. With the stock already down 5.1%, that worst-case scenario is more than priced in, leaving little reason to expect further declines.
Apple Unveils $20,000 Macs for Local AI, Shares Gain 0.8%
Apple pushed deeper into enterprise AI with new Mac Mini and Mac Studio systems designed to run powerful models locally instead of sending workloads to the cloud, sending shares up approximately 0.8% to $341.53 Tuesday. High-end configurations can approach $20,000, and Apple demonstrated four Mac Studios working together to run a trillion-parameter model from a single wall outlet, using RDMA-over-Thunderbolt technology to link the machines into a low-latency cluster. The challenge is distribution: Reuters cited IDC estimates showing Apple controls just 4.6% of enterprise computers, compared with 91.3% for Windows-based systems. Companies running AI models heavily enough could eventually prefer upfront equipment costs over ongoing cloud-token bills, while local processing adds privacy and more predictable spending. But investors already pay a premium, with the valuation snapshot putting Apple at $341.53 versus a GF Value of $286.67, or 19.14% above GF Value.
Defense Stocks Slide as Iran Offers to Reopen Strait of Hormuz
Aerospace and defense shares fell Tuesday morning after a Reuters report that Iran has offered to reopen the Strait of Hormuz within seven days if the U.S. takes initial steps toward easing military pressure. Lockheed Martin dropped 3% to $521.05 and RTX fell 3% to $189.40, while Boeing slipped 1% to $198.61, its smaller decline reflecting a revenue mix weighted toward commercial aircraft rather than munitions. The iShares U.S. Aerospace & Defense ETF fell 1% to $213.40 while the SPDR S&P 500 ETF Trust held roughly flat at $773.53, confirming the selling was concentrated in defense primes rather than the broader market. WTI crude oil traded at $91.64 per barrel, down 0.79% over the past 24 hours and lower for a fourth session, as the diplomatic signal compressed the geopolitical risk premium underpinning expectations for sustained munitions demand. The move extends an existing de-rating: RTX has shed 10% and Lockheed Martin 7% over the past month, making the Hormuz headline an accelerant rather than the ignition for the decline.
Alphabet opened preorders for its new Googlebook laptops at a starting price of $899, sending shares up approximately 1.72% to $356.915. The machines push Gemini deeper into Google's hardware ecosystem, letting the laptop use what is on the screen to assist users and move Android-phone tasks onto the device with less friction. Buyers receive 12 months of Google AI Pro and five terabytes of cloud storage, and Google is promising software support for up to a decade. Alphabet is trading 41.92% above its GF Value estimate of $251.49, a premium that leaves little room for a soft landing. The key test comes later: whether users keep paying once the promotional period ends and whether the $899 starting price turns Gemini enthusiasm into durable hardware and recurring-service revenue.
Bank of America Backs Tighter Guardrails for AI Shopping Agents
Bank of America has joined other major banks in pushing for tighter safeguards around AI shopping agents as autonomous commerce moves closer to mainstream payments. The banks want autonomous transactions to clearly disclose when an AI agent is involved, explain important purchasing decisions and protect customer information while keeping platforms interoperable. The bigger concern is what happens when a bot gets a transaction wrong, since automated purchasing could expose card credentials, steer consumers toward options with weaker protections and make responsibility for fraud harder to untangle. The stakes are large at Bank of America's scale: the company processed roughly $1.2 trillion in payments during the second quarter, while credit- and debit-card spending totaled about $266 billion. The bank's shares traded at $57.435 on Tuesday, and the stock sits 6.94% above its $53.71 GF Value.
Qualcomm's Snapdragon X Elite Lands in Dell's $1,199 XPS Googlebook
Dell has selected Qualcomm's Snapdragon X Elite chip for a flagship Googlebook, giving the wireless and computing-chip designer an early foothold in Google's new premium-laptop push. The $1,199 XPS Googlebook pairs the Snapdragon X Elite with a claimed battery life of up to 18 hours, a high-profile showcase for Qualcomm's Windows-rivaling PC ambitions. Google's broader rollout stretches across Acer, Asus, Dell, HP and Lenovo, though the company has not disclosed how many of those machines will run Qualcomm silicon versus Intel processors, leaving unresolved whether Snapdragon can move from a showcase design into meaningful share across the wider Googlebook ecosystem. Qualcomm shares slipped approximately 0.3% to $193.59, a price that sits 10.32% above the $175.48 GF Value estimate, suggesting the market already prices in a healthy dose of future growth. One premium Dell win proves Snapdragon can compete for marquee designs, but the bigger catalyst would be repeat adoption across multiple manufacturers, stronger software compatibility and enough PC volume to make Qualcomm materially less dependent on smartphones.
Microchip Shares Up 17.3% YTD as Data-Center Revenue Targets $1 Billion
Microchip Technology shares have risen 17.3% year to date, underperforming the Zacks Computer and Technology sector's 19.8% gain, as the company leans on data-center, aerospace and defense growth to offset supply constraints and elevated debt. Microchip expects total data-center revenues to rise roughly 69% from about $591 million in calendar 2025 to approximately $1 billion in 2026, with 14 PCIe Gen6 design wins as of September, comprising 12 PCIe switch wins and two retimer wins, expected to generate meaningful revenues in calendar 2027. The company estimates the longer-term PCIe and retimer addressable markets at roughly $10 billion and $2 billion, respectively, while industrial revenues rose 24.3% year over year and automotive revenues increased 29.3% year over year in the first quarter of fiscal 2027, and aerospace and defense revenues climbed 45.6% year over year to represent 16.7% of sales. Microchip had $5.36 billion of long-term debt as of June 30, 2026, and about 65% of its wafer fabrication is externally sourced, leaving it exposed to foundry, substrate and test capacity constraints. The Zacks Consensus Estimate for fiscal 2027 earnings is $3.63 per share, unchanged over the past 30 days and indicating 121.34% growth over fiscal 2026, with fiscal 2027 revenues pegged at $6.41 billion, suggesting 35.91% growth, while second-quarter fiscal 2027 net sales are guided to $1.59 billion to $1.618 billion and non-GAAP earnings to 91-95 cents per share. Microchip currently carries a Zacks Rank #3 (Hold).
PayPal Jumps 3% on Meta AI Checkout Deal as Financial Stocks Slide
PayPal Holdings Inc. shares rose 3% after the payments company announced a strategic partnership with Meta Platforms Inc. that will let customers shop and check out using Meta's Muse personal AI agents across PayPal's global merchant network. The integration aims to combine AI-powered shopping with PayPal's payment infrastructure, letting users complete commerce transactions through Meta's AI technology while keeping PayPal as their designated payment method. The news came as investors rotated aggressively into technology stocks on enthusiasm for Meta's Muse AI agent, hitting traditional banking and wealth management hard. Charles Schwab Corp. led the financial decliners with a 6.7% drop, followed by Allstate Corp. at 5.0%, Raymond James Financial Inc. at 4.5%, Ameriprise Financial Inc. at 3.8%, Progressive Corp. and State Street Corp. each at 3.2%, and Brown & Brown Inc. at 3.1%. Among major banks, Morgan Stanley fell 3.5%, Bank of America dropped 3.4%, JPMorgan Chase & Co. slid 3.0%, and Northern Trust Corp. lost 2.7%.
Micron Reclaims $1,000 as SCA Floor Pricing Reshapes Memory Cycle
Micron Technology shares have climbed back above $1,000, trading at $1,043.96, after a pullback briefly pushed the stock below that mark. The company's Strategic Customer Agreement framework now covers 16 agreements representing roughly 20% of DRAM volume and a third of NAND volume, locking in $100 billion in cumulative minimum revenue and take-or-pay commitments with floor pricing that management says supports margins significantly above prior peak margins. Fiscal Q3 revenue reached $41.46 billion, up 345.7% year over year, with gross margin of 84.9% and free cash flow of $18.3 billion, while Q4 guidance calls for $50 billion in revenue and EPS near $31. Micron trades at roughly 7x forward earnings against a mean analyst target of $1,513.11, though bears point to a 542.57% one-year surge, about $27 billion in fiscal 2026 capex, and a beta of 2.222 that amplifies any hyperscaler spending pullback. The bull case hinges on the fiscal Q4 report confirming the $50 billion revenue figure and the calendar 2027 HBM4E ramp, with roughly half of company revenue eventually contracted at floor prices above prior peak margins.
Alibaba Unveils China's Most Powerful AI Chip; On Holding Eyes High-Teens Sales Growth
Alibaba shares rose more than 3% after the company unveiled what it called China's most powerful AI chip, claiming three times the performance of its previous generation, and announced plans to expand data center capacity and train a new AI model at the scale of 5 to 10 trillion parameters. On Holding shares climbed 11% as the Swiss sneaker maker said it expects sales growth in the high teens over the next few years while moving into sports including golf and football, though the stock remains down 41% year to date. Viking Therapeutics shares surged about 30% in pre-market trading, having earlier been up more than 50%, after the biotech reported positive top-line results from its VK2735-102 maintenance study showing its experimental obesity drug VK2735 maintained up to 97% of weight loss versus 61% for placebo when subjects switched to every-other-week dosing, with Leerink analysts calling the data stellar and saying it strengthens the drug's competitive profile. The study showed the drug led to 22% weight loss over 33 weeks, positioning it as a potential contender to Eli Lilly and Novo Nordisk. Roche also released positive trial data on its obesity treatment, adding to intensifying competition that left Eli Lilly and Novo Nordisk shares slightly lower.
AECOM Shares Fall 30% in Six Months on $337 Million Project Charge
AECOM shares have dropped 30.1% over the past six months, underperforming the Zacks Engineering - R and D Services industry's 2.7% gain, the broader Zacks Construction sector's 4% drop and the S&P 500 Index's 16% rise over the same period. The decline reflects a $337 million pre-tax charge recorded in the third quarter of fiscal 2026 tied to a delayed Construction Management project, where weaker-than-expected subcontractor productivity raised completion costs and pushed substantial completion into the second quarter of fiscal 2027. For the first nine months of fiscal 2026, operating cash flow fell to $169.2 million from $625.5 million a year earlier, and the company now expects full-year free cash flow of approximately $300 million, with higher expected debt balances and lower cash levels projected to increase fiscal 2027 net interest expense by $30-$35 million. Fiscal 2026 earnings estimates have moved down to $4.48 per share over the past 60 days, implying a year-over-year decline of 14.8%, while fiscal 2027 estimates declined to $5.99 over the past 30 days, pointing to growth of 33.7%. AECOM's backlog reached a record $27.8 billion in the fiscal third quarter, up 13%, supported by record quarterly wins of $4.2 billion and a 1.6x book-to-burn ratio, and the company has returned more than $3.5 billion to shareholders since September 2020.
Teekay Tankers Stock Slips as Iran Offers to Reopen Strait of Hormuz
Teekay Tankers stock fell 2.9% through 10:55 a.m. ET, giving back part of a September rally that had lifted shares as much as 14% through Friday's close. The maritime services provider, which gets 87% of its revenue from its tanker business, had climbed as charter rates spiked: StreetInsider.com reported the cost of chartering a Very Large Crude Carrier supertanker passed $1 million per day, up 5 times from what chartering a supertanker cost before the Iran war began Feb. 28. The Baltic Dirty Tanker Index closed just below 2,000 before the war, hit 2,421 at the beginning of September, and has more than doubled this month to 5,092, a spike StreetInsider attributes to a near-shutdown of Hormuz traffic. Today's decline follows a Reuters report that Iran offered over the weekend to reopen the Strait of Hormuz within seven days if the United States Navy lifts its blockade of Iranian shipping, which would let oil move again and make tankers easier and cheaper to charter. The article notes this is not the first time rumors that the Iran war is about to end have pushed oil stocks lower, and that if the rumors prove false, charter rates and Teekay stock could go right back up.
Intuitive Surgical Wins World-First CE Mark for da Vinci SP Transvaginal Surgery
Intuitive Surgical received CE mark approval earlier this month for using its da Vinci SP single-port robotic system in transvaginal gynecologic procedures, a world-first indication for the SP platform that adds to its existing European approvals for a range of endoscopic and natural-orifice surgeries. The approval broadens the SP system's clinically supported use in complex anatomical spaces and deepens the company's position in minimally invasive, scarless surgery. The new indication is unlikely to shift near-term catalysts in a major way, as Intuitive Surgical continues to manage multiple Class II recalls, execute on its ambulatory surgery center push, and justify a rich earnings multiple after a sharp year-to-date share price pullback. Eleven fair value views from the Simply Wall St Community range from about US$324 to over US$630 per share, underscoring how differently investors frame the company's prospects.
US Household Equity Share Hits Record 39.9% of Net Worth, Topping Real Estate
US households now hold a record share of their net worth in stocks, with corporate equities accounting for 39.9% of household net worth, the largest share in Federal Reserve records. Owners' equity in residential real estate fell to 19.3% in the same quarter, leaving a gap of 20.6 percentage points between the two measures, according to the Fed's quarterly Financial Accounts report cited by the Kobeissi Letter. Households held $185.65 trillion in net worth over the period, of which directly and indirectly held corporate equities accounted for $74.03 trillion, while owners' equity in residential real estate, calculated by subtracting mortgage debt from home values, totaled $35.81 trillion. Equity exposure has climbed 12.6 percentage points since the third quarter of 2022, while the housing share lost 3.5 points over the same stretch, a reversal from the third quarter of 2005 when real estate exposure peaked at 24.1%, one point above equities. Market returns explain most of the shift, with the Nasdaq Composite closing at a record 27,122.09 on September 21, a gain of 16.7% for the year, and the S&P 500 finishing the same session at 7,764.70, up 13.4% in 2026, while the Case-Shiller national home price index rose just 1.5% in the year through June against 3.5% inflation. Forecasts for the rest of the year for the S&P 500 range from 7,400 to 8,100, with Bank of America holding the lowest target at 7,400, implying a decline of roughly 4.7% from Monday's close, and the next Financial Accounts release in December will show whether the third quarter widened the gap further.
Berkshire Hathaway Raises Stake in Lennar, Shares Jump 4.44%
Berkshire Hathaway has increased its stake in homebuilder Lennar, sending the company's shares 4.44% higher to $81.55 in morning trading on Tuesday. An SEC filing showed that Berkshire, already a 10% owner of Lennar, acquired roughly 2.74 million class A and B shares in multiple transactions at prices ranging from $74.49 to $79.79. Following the purchases, Berkshire holds approximately 23.72 million class A shares and 528,217 class B shares, both of indirect ownership. The move comes after Warren Buffett, who led Berkshire Hathaway for 61 years, stepped down as chairman.
Intel stock jumps 25% in five days as AI agent demand lifts CPUs
Intel shares climbed 25% over the last five days as demand for central processing units rises with the spread of agentic AI. CEO Lip-Bu Tan said at the AI Infra Summit that CPUs are in high demand for reinforcement learning, agentic AI, system-level orchestration, and their general-purpose usefulness, since CPUs are the chips that let AI agents navigate websites, shop online, and perform other tasks while GPUs run the underlying models. Intel is also reportedly expected to raise CPU prices 10%, according to Digitimes, and Meta's new Muse AI agent has drawn 2.5 million downloads since its Sept. 8 launch, per Sensor Tower. The company is pursuing a broader turnaround and building a third-party chip manufacturing business to compete with Taiwan Semiconductor Manufacturing Company, with Google having chosen Intel in June to make its custom Tensor Processing Units, Nvidia looking at Intel as a backup chip builder, and Reuters reporting SK Hynix is in talks with Intel to produce memory chips. Intel shares are up 159% over the last five months, 314% over the last 12 months.
Marram Exits PayPal Stake After Board Abruptly Replaces CEO
Marram Investment Management exited its position in PayPal Holdings at a slight loss during the second quarter of 2026 after its investment thesis broke when the company's Board abruptly fired the CEO and appointed a successor, a former HP executive with no payments, technology, or product experience. The firm disclosed the move in its second-quarter 2026 investor letter, which reported a portfolio return of +2.7% net of fees for the quarter and +3.2% year-to-date, with a cumulative return of +632.4% and a +13.7% annualized return since inception. Marram said its original thesis rested on a capable management team investing to rebuild PayPal's technology, product, and brand, and that it acted when the facts changed. PayPal closed at $52.62 per share on September 21, 2026, down 15.50% over the past month and 21.82% over the past year, with a market capitalization of $45.01 billion and a 52-week range of $38.46 to $79.22. The number of hedge fund portfolios holding PayPal fell to 60 at the end of the second quarter from 76 in the previous quarter.
On Holding Shares Jump 14% After Investor Day Lays Out 2029 Plan
On Holding shares rose more than 14% in early trading after the company used its Investor Day to lay out financial and product strategy through 2029. Management committed to maintaining a gross profit margin of at least 65% through 2029, well above Nike's most recent annual gross profit margin of about 43%. The company reiterated its full-year 2026 guidance for net sales growth of over 20% on a constant currency basis, and announced plans to repurchase up to $1 billion in shares through 2029. On also said it will enter the soccer market, naming French soccer star Kylian Mbappé as its global ambassador. The stock has lost one-third of its value this year, and investors appeared to call a bottom on the shares after the event.
Bitcoin ETFs Draw Nearly $1 Billion In Largest One-Day Inflow Since October 2025
Spot Bitcoin exchange-traded funds attracted nearly $1 billion U.S. of capital on Sept. 21 as the rally in cryptocurrencies strengthens. About a dozen U.S. Bitcoin ETFs registered a combined net inflow of $998.95 million U.S., the largest one-day intake since Oct. 6, 2025, when BTC hit a record high of $126,000 U.S. The inflow was the ninth-largest one-day total since the ETFs began trading on Jan. 11, 2024, according to data from SoSoValue. The Sept. 21 inflow has taken the month-to-date tally to $1.31 billion U.S. during September, building on August's $3.52 billion U.S. capital inflow to Bitcoin ETFs. The renewed institutional interest comes as Bitcoin's price has surged 44% over the past month to trade at $86,000 U.S. on Sept. 22, though owing to big redemptions earlier in the year, spot Bitcoin ETFs remain down $450 million U.S. in 2026.
Moderna Jumps 5% as 1,137-Patient Melanoma Data Looms on October 24
Moderna shares rose another 5% to $181.51 on Tuesday morning, extending a 516% year-to-date gain, as investors position ahead of a late-October readout for the company's personalized cancer therapy. Moderna said detailed Phase 3 results for intismeran autogene, developed with Merck, will be presented at the European Society for Medical Oncology Congress in a Presidential Symposium on October 24. The data come from the INTerpath-001 study, which enrolled 1,137 participants and tested intismeran plus Merck's Keytruda against Keytruda alone in high-risk melanoma patients whose tumors had been surgically removed; Moderna reported last month that the trial met its primary endpoint of recurrence-free survival and a key secondary endpoint of distant metastasis-free survival, with both companies calling the improvements statistically significant and clinically meaningful, but releasing no underlying numbers. BioNTech, the other large messenger RNA developer, is up just 5% year to date at $100.42, a contrast that suggests the market is pricing an intismeran-specific outcome rather than a broad re-rating of the mRNA platform. Moderna and Merck are running intismeran across nine mid-stage and late-stage studies in other tumor types, including non-small cell lung cancer, bladder cancer and renal cell carcinoma, so the October 24 hazard ratios and survival curves carry binary risk for a stock that has rallied on a top-line conclusion rather than a dataset.
Meta Rallies Nearly 30% as Muse AI Launch and JPMorgan Upgrade Reframe Capex Debate
Meta Platforms has clawed back nearly 30% over the past month, outperforming the broader market ahead of its Connect 2026 event on September 23rd, after a summer in which the stock fell 13% in 2026 while the S&P 500 gained more than 10%. The rebound follows a second quarter in which revenue grew 28% to $60.8 billion but earnings of $6.18 per share missed the roughly $7.10 consensus, as capital expenditures hit $31.1 billion, up 57% from the first quarter and consuming about 98% of the company's $31.86 billion in operating cash flow, leaving free cash flow at $784 million. Management narrowed its 2026 capex guidance to $130 billion to $145 billion, nearly double the $72.2 billion spent in 2025, took on another $24.9 billion of debt to bring long-term debt to $83.7 billion, and repurchased zero shares for a second straight quarter after buying back $26.3 billion in 2025. Earlier this month Meta launched Muse, a personal AI agent powered by its Muse Spark family of models, which reached as high as No. 3 in the U.S. App Store on its second day with early usage running roughly ten times that of internal testing cohorts, and JPMorgan analyst Doug Anmuth wrote that Meta's Superintelligence Lab essentially delivered on its goal of reaching the frontier within a year with Muse Spark 1.3. JPMorgan upgraded the stock to Overweight from Neutral and raised its price target to $820 from $640, while advertising revenue grew 27% to $59.4 billion in the second quarter on 14% growth in ad impressions and a 12% increase in average price per ad, and CEO Mark Zuckerberg noted on the second-quarter call that Meta is receiving offers for its computing capacity at a significant premium to what the company paid for it.